4//SEC Filing
Eleven Biotherapeutics, Inc. 4
Accession 0001485003-16-000122
$CARMCIK 0001485003operating
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:16 PM ET
Size
5.2 KB
Accession
0001485003-16-000122
Insider Transaction Report
Form 4
Tubridy Karen L
Chief Development Officer
Transactions
- Sale
Common Stock
2016-06-27$2.08/sh−4,372$9,094→ 32,753 total
Footnotes (2)
- [F1]The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.
- [F2]Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $2.00 to $2.11 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001485003
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 4:16 PM ET
- Size
- 5.2 KB